T Stamp Inc Earnings Per Share Disclosure
| For the years ended December 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Numerator: | ||||||||||||||
| Net loss attributable to common stockholders | $ | (8,325,099) | $ | (12,544,593) | ||||||||||
| Denominator: | ||||||||||||||
| Weighted average shares used in computing net loss per share attributable to common stockholders | 3,112,440 | 1,104,225 | ||||||||||||
| Net loss per share attributable to common stockholders | $ | (2.67) | $ | (11.36) | ||||||||||
| As of December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Options, RSUs, and grants | 511,329 | 103,521 | |||||||||
| Warrants | 3,501,133 | 1,826,593 | |||||||||
| Total | 4,012,462 | 1,930,114 | |||||||||
Want the next T Stamp Inc earnings per share disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment T Stamp Inc's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 31, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
| 2023 | Apr 1, 2024 | |
| 2022 | Mar 30, 2023 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.